Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of DR-102 for Pregnancy Prevention
NCT01178125Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Aug 2010
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ethinyl estradiol + desogestrel in contraception, sponsored by Teva Pharmaceutical Industries Ltd.. Started Aug 2010; status: completed.
02
Drugs
ethinyl estradiol + desogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NCT01178125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01178125.